Walgreens to Shelve Boots IPO Plans as Sale Talks Continue, Bloomberg Says (2024)

Market Closed - Nasdaq Other stock markets 21:00:00 07/06/2024 BST			5-day change	1st Jan Change
15.84 ^USD	-0.13%		-2.34%	-39.33%

06-08	Walgreens Reportedly Shelves Plans for Boots IPO as Sale Talks Continue	CI
06-08	Top law firms in US opioid lawsuits to get hundreds of millions in fees	RE

This article is reserved for members

Latest news about Walgreens Boots Alliance, Inc.

Walgreens Reportedly Shelves Plans for Boots IPO as Sale Talks Continue	06-08	CI
Top law firms in US opioid lawsuits to get hundreds of millions in fees	06-07	RE
CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation	06-07	DJ
CityMD Agrees to $12 Million to Pay Department of Justice Over Alleged Covid-19 Payments Violation -- Update	06-07	DJ
Sector Update: Health Care Stocks Higher Late Afternoon	06-07	MT
Sector Update: Health Care	06-07	MT
Walgreens Shelves Boots IPO Plans, Explores Other Options	06-07	MT
Walgreens Shelves Boots IPO Plans, Explores Other Options	06-07	MT
Walgreens shelves plans for Boots IPO, Bloomberg News reports	06-07	RE
Walgreens to Shelve Boots IPO Plans as Sale Talks Continue, Bloomberg Says	06-07	MT
Leerink Adjusts Price Target on Walgreens Boots Alliance to $17 From $22	06-06	MT
Evercore ISI Adjusts Price Target on Walgreens Boots Alliance to $17 From $18, Keeps In Line Rating	06-03	MT
Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $13 From $16, Maintains Underweight Rating	05-31	MT
Price cuts, weaker spending may boost Fed's faith in inflation outlook	05-31	RE
Nvidia soon to join the Dow Jones?	05-29
Health Care Limits Losses Amid Defensive Bias - Health Care Roundup	05-23	DJ
Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney...	05-23
The market is good to go until Nvidia’s next quarterly results	05-23
Walgreens Boots Alliance Sells $400 Million of Cencora Shares	05-23	MT
Walgreens further cuts stake in drug distributor Cencora	05-22	RE
Walgreens reduces stake in Cencora	05-22	RE
Advanced Oxygen Therapy plans London float - Sky News	05-16	AN
Walgreens to Sell Over-the-Counter Naloxone Anti-Narcotic Spray to Reverse Opioid Overdoses	05-15	MT
Walgreens Announces Launch of Walgreens Brand Naloxone HCI Nasal Spray	05-15	CI
Raspberry Pi helps lift gloom over London IPO market	05-15	AN

Chart Walgreens Boots Alliance, Inc.

Duration

Period

More charts

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows:- retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet;- wholesale distribution (8.1%).The remaining sales (4.7%) are from the healthcareNet sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).

Sector

Drug Retailers

Calendar

27/06/2024 - Q3 2024 Earnings Release

Related indices

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Walgreens CEO on Narrowed Forecast, Shoppers Cutting Back Spending March 28, 2024 at 07:59 pm

Walgreens Boots Alliance, Inc. first light at the end of the tunnel? November 27, 2023 at 03:22 pm

More Strategies

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

15.84USD

Average target price

22.21USD

Spread / Average Target

+40.20%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
WALGREENS BOOTS ALLIANCE, INC.	-39.33%	13.67B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-8.96%	7.95B
YIFENG PHARMACY CHAIN CO., LTD.	+4.90%	5.86B
	-14.18%	5.71B
NAHDI MEDICAL COMPANY	-3.07%	4.6B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+70.58%	4.5B
CLICKS GROUP LIMITED	-8.29%	3.77B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-22.05%	3.05B
WELCIA HOLDINGS CO., LTD.	-12.92%	2.81B
REDCARE PHARMACY NV	-11.32%	2.57B

Other Drug Retailers

Stock Market
Equities
WBA Stock
News Walgreens Boots Alliance, Inc.
Walgreens to Shelve Boots IPO Plans as Sale Talks Continue, Bloomberg Says

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities. BENEFIT NOW

"); InvestingChannelQueue.push(function() { aICTags["oop"] = ic_page.defineOutOfPageTag("4Traders/quotepages","zppOOP"); aICTags["oop"].setKval({"adslot":"d_OOP_1"}); aICTags["oop"].render(); }); while (aAdsQueue.length) { (aAdsQueue.shift())(); } InvestingChannelQueue.push(function() { displayViewableAds('InvestingChannel'); $( window ).scroll(function() { displayViewableAds('InvestingChannel'); }); }); }gaEvent('adspv', 'InvestingChannel', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_GB');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '19356230');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });